Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Organon & Co..
IPO Date: May 14, 2021
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Cap: $2.7B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.36 | 1.64%
Avg Daily Range (30 D): $0.24 | 2.45%
Avg Daily Range (90 D): $0.24 | 2.46%
Institutional Daily Volume
Avg Daily Volume: 2.34M
Avg Daily Volume (30 D): 3.76M
Avg Daily Volume (90 D): 4.43M
Trade Size
Avg Trade Size (Sh.): 99
Avg Trade Size (Sh.) (30 D): 134
Avg Trade Size (Sh.) (90 D): 140
Institutional Trades
Total Inst.Trades: 3,868
Avg Inst. Trade: $3.51M
Avg Inst. Trade (30 D): $3.44M
Avg Inst. Trade (90 D): $3.51M
Avg Inst. Trade Volume: .17M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $8.05M
Avg Closing Trade (30 D): $4.83M
Avg Closing Trade (90 D): $6.16M
Avg Closing Volume: 391.35K
   
News
Aug 14, 2025 @ 8:18 PM
Daré Bioscience Posts Narrower Q2 Loss
Source: Jesterai
Jul 23, 2025 @ 5:00 PM
Global Dysmenorrhea Treatment Market to Cross ~USD...
Source: Delveinsight
Jul 21, 2025 @ 8:00 PM
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman ...
Source: Bronstein, Gewirtz & Grossman Llc
Jul 21, 2025 @ 5:47 PM
UPDATE - Daré Bioscience to Host August 6 Webin...
Source: Daré Bioscience, Inc.
Jul 20, 2025 @ 2:55 PM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LL...
Source: Faruqi & Faruqi, Llp
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $2.71 $.56 $.34
Diluted EPS $2.68 $.56 $.33
Revenue $ 6.28B $ 1.59B $ 1.51B
Gross Profit $ 3.53B $ 874M $ 841M
Net Income / Loss $ 700M $ 145M $ 87M
Operating Income / Loss $ 666M $ 229M $ 101M
Cost of Revenue $ 2.75B $ 720M $ 672M
Net Cash Flow $ -105M $ 52M $ -128M
PE Ratio 3.90